Showing results (1731-1740 of 1,842) with videos related to

Sort By:
Pageof 185
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4M P Reddy, C A Kinney, M A Chaikin, et al.
Journal of Proteome Research|March 22, 2007
Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkersSrinivasa R Nagalla, Jacob A Canick, Thomas Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTENDAlexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
The Journal of Molecular Diagnostics : JMD|April 17, 2023
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid TumorsEllen L Verner, Jennifer B Jackson, Eric Severson, et al.
Head & Neck|August 11, 2020
Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomesAlexander F Bagley, Adam S Garden, Jay P Reddy, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2007
Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in miceSrinivas Papaiahgari, Adi Yerrapureddy, Swetha R Reddy, et al.
The Lancet. Global Health|July 15, 2022
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysisEsther E Freeman, Nicole C McCann, Aggrey Semeere, et al.
Journal of Thoracic Imaging|January 25, 2011
ACR Appropriateness Criteria® screening for pulmonary metastasesTan-Lucien H Mohammed, Aqeel Chowdhry, Gautham P Reddy, et al.
Clinical Lung Cancer|October 13, 2004
Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trialPrimo N Lara, Paul H Gumerlock, Philip C Mack, et al.
Frontiers in Cellular Neuroscience|June 5, 2023
Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitorSophie Colombo, Haritha P Reddy, Sabrina Petri, et al.
Pageof 185